| Molecular Formula | C75H118N20O22S |
| Molar Mass | 1683.93 |
| Density | 1.334±0.06 g/cm3(Predicted) |
| Boling Point | 1982.4±65.0 °C(Predicted) |
| Appearance | solid |
| pKa | 3.12±0.10(Predicted) |
| Storage Condition | -20°C |
| In vitro study | NFAT Inhibitor treatment significantly inhibits nuclear translocation of NFATc1 for 24 hours. Long-term treatment with VIVIT significantly inhibits the cytoplasmic levels of cathepsin K, TRAP, and MMP-9. Western Blot Analysis Cell Line: Human peripheral blood CD14 + monocytes Concentration: 10 μM Incubation Time: 24 hours or 21 days Result: Short-term treatment with 10 μM, significantly inhibited nuclear translocation of NFATc1. Long-term treatment, significantly inhibited the cytoplasmic levels of cathepsin K, TRAP, and MMP-9. |
| Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 0.594 ml | 2.969 ml | 5.938 ml |
| 5 mM | 0.119 ml | 0.594 ml | 1.188 ml |
| 10 mM | 0.059 ml | 0.297 ml | 0.594 ml |
| 5 mM | 0.012 ml | 0.059 ml | 0.119 ml |